AQST Aquestive Therapeutics, Inc.
Nasdaq · SEC CIK 1398733 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $3.59M 19 sales by 9 insiders
- Filings on record
- 160 since 2021-08-27, latest 2026-09-16 14:00
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Barber Daniel | Pres, CEO, Dir | — | $1.77M |
| Jung Cassie | COO | — | $664.6K |
| Boyd Peter E. | See Remarks | — | $257.3K |
| TOTH A ERNEST JR | CFO | — | $242.9K |
| BRAENDER LORI J | Corp. Sec | — | $167.2K |
| Kraus Carl N | Chief Medical Off | — | $141.9K |
| Krop Julie | Dir | — | $125.4K |
| Korczynski Sherry | Chief Commercial Off | — | $111.3K |
| Cioffi Melina | SVP, Regulatory Affairs | — | $105.5K |
| Zalewski Thomas A. | CLO | — | — |
Transactions 115
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-09 | 2023-03-09 | AQST | TOTH A ERNEST JR | SVP, CFO | A - Grant | $0.00 | +140.0K | 140.0K | New | $0 | |
| 2023-03-09 | 2023-03-09 | AQST | Schobel Alexander Mark | Chief Innovation, Tech Off | A - Grant | $0.00 | +100.0K | 982.9K | +11% | $0 | |
| 2023-03-09 | 2023-03-09 | AQST | Barber Daniel | Pres, CEO | A - Grant | $0.00 | +447.0K | 640.7K | +231% | $0 | |
| 2023-03-09 | 2023-03-09 | AQST | Wargacki Stephen | SVP, Research, Development | A - Grant | $0.00 | +135.0K | 162.0K | +501% | $0 | |
| 2023-03-09 | 2023-03-09 | AQST | Marshall Ken W. | SVP, Chief Commercial Off | A - Grant | $0.00 | +150.0K | 150.0K | New | $0 | |
| 2023-03-09 | 2023-03-09 | AQST | Jung Cassie | SVP, Ops | A - Grant | $0.00 | +110.0K | 146.7K | +299% | $0 | |
| 2023-03-09 | 2023-03-09 | AQST | Boyd Peter E. | See Remark | A - Grant | $0.00 | +100.0K | 159.5K | +168% | $0 | |
| 2023-03-09 | 2023-03-09 | AQST | BRAENDER LORI J | SVP, GC | A - Grant | $0.00 | +150.0K | 188.8K | +387% | $0 | |
| 2022-06-15 | 2022-06-14 | AQST | Boyd Peter E. | SVP-Bus. Process, Info. Tech | P - Purchase | $0.81 | +5,000 | 59.5K | +9% | +$4,050 | |
| D | 2022-06-10 | 2022-06-08 | AQST | Schobel Alexander Mark | Chief Innovation, Tech Off | P - Purchase | $0.96 | +45.9K | 882.9K | +5% | +$44.0K |
| D | 2022-06-10 | 2022-06-08 | AQST | BRAENDER LORI J | GC | P - Purchase | $0.96 | +13.8K | 38.8K | +55% | +$13.2K |
| D | 2022-06-10 | 2022-06-08 | AQST | Boyd Peter E. | SVP-Bus. Process, Info. Tech | P - Purchase | $0.96 | +2,293 | 54.5K | +4% | +$2,201 |
| D | 2022-06-10 | 2022-06-08 | AQST | Barber Daniel | CEO | P - Purchase | $0.96 | +91.7K | 193.7K | +90% | +$88.1K |
| I | 2021-08-27 | 2021-08-26 | AQST | Kendall Keith J | CEO, Pres, Dir | G - Gift | — | +1,000 | 1,000 | New | — |
| 2021-08-27 | 2021-08-26 | AQST | Kendall Keith J | CEO, Pres, Dir | G - Gift | — | -1,000 | 636.1K | -0.2% | — |
Purchase Sale Sale after option exercise All abbreviations